DrugPatentWatch Database Preview
ROPINIROLE HYDROCHLORIDE Drug Profile
or, see our see our flat-rate plans
When do Ropinirole Hydrochloride patents expire, and when can generic versions of Ropinirole Hydrochloride launch?
The generic ingredient in ROPINIROLE HYDROCHLORIDE is ropinirole hydrochloride. There are fourteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ropinirole hydrochloride profile page.
Summary for ROPINIROLE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 19 |
| Suppliers / Packagers: | 29 |
| Bulk Api Vendors: | 91 |
| Clinical Trials: | 69 |
| Patent Applications: | 1,055 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ROPINIROLE HYDROCHLORIDE |
| DailyMed Link: | ROPINIROLE HYDROCHLORIDE at DailyMed |
Pharmacology for ROPINIROLE HYDROCHLORIDE
| Drug Class | Nonergot Dopamine Agonist |
| Mechanism of Action | Dopamine Agonists |
Synonyms for ROPINIROLE HYDROCHLORIDE
| 1,3-Dihydro-4-(2-(dipropylamino)ethyl)-2H-indol-2-one monohydrochloride |
| 2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride |
| 2H-Indol-2-one, 1,3-dihydro-4-(2-(dipropylamino)ethyl)-, monohydrochloride |
| 374R208 |
| 4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochloride |
| 4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride |
| 4-(2-(Dipropylamino)ethyl)indolin-2-onehydrochloride |
| 4-(2-di-n-propylaminoethyl)-2(3H)-indolone hydrochloride |
| 4-(2-di-n-propylaminoethyl)-2(3H)indolone hydrochloride |
| 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one hydrochloride |
| 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone Hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride |
| 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]indolin-2-one hydrochloride |
| 4CA-1107 |
| 91374-20-8 |
| 91374-20-8,91374-21-9(freebase) |
| 91374-21-9 (base) |
| 91374-21-9 (Parent) |
| A843815 |
| AB0009822 |
| ABP000199 |
| AC-735 |
| AC-736 |
| AC1L2ABS |
| AC1Q3EQJ |
| ACT02690 |
| Adartrel |
| AK-59618 |
| AKOS015844988 |
| AN-15584 |
| ANW-58872 |
| BC207366 |
| BS-1020 |
| CCG-213346 |
| CHEBI:8889 |
| CHEMBL1200411 |
| CS-2864 |
| CTK8B7890 |
| D00784 |
| D7ZD41RZI9 |
| DTXSID50238533 |
| EBD38503 |
| EU-0101101 |
| FC0024 |
| FT-0642200 |
| HP-3000 |
| HY-B0623A |
| I06-0693 |
| JZP-7 |
| KB-80420 |
| KS-000011L6 |
| KS-00002WRZ |
| LP01101 |
| LS-83828 |
| M-1298 |
| MCULE-8190476072 |
| MFCD01754173 |
| MLS003899234 |
| MolPort-003-987-439 |
| NCGC00094373-01 |
| NCGC00261786-01 |
| NP-201 |
| NVD-434 |
| R 4152 |
| Repreve |
| Requip (TN) |
| ReQuip LP |
| ReQuip PR |
| ReQuip XR |
| Ropinirole (hydrochloride) |
| Ropinirole for peak identification 1, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole for peak identification 2, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole HCl |
| Ropinirole hydrochloride (JAN/USAN) |
| Ropinirole hydrochloride [USAN:USP] |
| Ropinirole hydrochloride [USAN] |
| Ropinirole hydrochloride, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur |
| Ropinirole hydrochloride, powder, >=98% (HPLC) |
| Ropinirole hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Ropinirole hydrochloride; |
| Ropinirole hydrochloride/ |
| Ropinirolehydrochloride |
| Ropinirolhydrochloride |
| s3189 |
| SCHEMBL40760 |
| SK&F 101468-A |
| SK&F-101468-A |
| SK&F-101468A |
| SKF 101468 hydrochloride |
| SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
| SKF-101468A |
| SMR001456484 |
| SR-01000076215 |
| SR-01000076215-2 |
| ST24042825 |
| ST51051236 |
| TC-030791 |
| TL8005858 |
| Tox21_501101 |
| UNII-D7ZD41RZI9 |
| XDXHAEQXIBQUEZ-UHFFFAOYSA-N |
| Z1695926158 |
US Patents and Regulatory Information for ROPINIROLE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Generics | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 090135-001 | Feb 25, 2010 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| West-ward Pharms Int | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 077852-002 | May 5, 2008 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Accord Hlthcare | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 204022-005 | Feb 28, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Wockhardt Ltd | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091395-001 | Aug 27, 2012 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
